Human mucormycosis; current perspectives

Mucormycosis commonly referred to as black fungus, is an invasive life-threatening fungal infection mainly caused by the opportunistic fungi, belonging to the order Mucorales. While occurrences of mucormycosis were historically infrequent, the onset of the second wave of the COVID-19 pandemic witnessed a dramatic surge in cases, prompting global concern. Mucorales fungi exist on natural habitats like soil and decaying organic matter, facilitates transmission through inhalation, ingestion, or direct spore inoculation. The clinical spectrum of mucormycosis ranges from less severe cutaneous manifestations to severe, life-threatening disseminated disease, contingent upon both the virulence of the fungus and the immune status of the host. Recognizing its clinical manifestations and risk factors assumes paramount importance, as early diagnosis and intervention are critical in averting progression to a potentially fatal outcome. This review provides a comprehensive overview encompassing the causative organism, epidemiology, pathogenesis, clinical manifestations, therapeutic strategies, and preventive measures concerning human mucormycosis, while summarizing the single center experience of mucormycosis during one-year period at a Teaching Hospital situated in Sri Lanka.

Authors

Institutions

Publication Details

Journal
Reviews in Medical Microbiology
Published
2026-06-17
DOI
https://doi.org/10.1097/mrm.0000000000000457
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human mucormycosis; current perspectives

A S Jayaweera, Madhawa W. Bandara, Shobha S. Gunathilaka, Ashani C. Adhikari et al.
Reviews in Medical Microbiology
Antifungal resistance and susceptibility
article

Human mucormycosis; current perspectives

A S Jayaweera, Madhawa W. Bandara, Shobha S. Gunathilaka, Ashani C. Adhikari, Anjalina R.P. Thalagala, Kulasekarage C. Madhuwantha
article en

Abstract

Mucormycosis commonly referred to as black fungus, is an invasive life-threatening fungal infection mainly caused by the opportunistic fungi, belonging to the order Mucorales. While occurrences of mucormycosis were historically infrequent, the onset of the second wave of the COVID-19 pandemic witnessed a dramatic surge in cases, prompting global concern. Mucorales fungi exist on natural habitats like soil and decaying organic matter, facilitates transmission through inhalation, ingestion, or direct spore inoculation. The clinical spectrum of mucormycosis ranges from less severe cutaneous manifestations to severe, life-threatening disseminated disease, contingent upon both the virulence of the fungus and the immune status of the host. Recognizing its clinical manifestations and risk factors assumes paramount importance, as early diagnosis and intervention are critical in averting progression to a potentially fatal outcome. This review provides a comprehensive overview encompassing the causative organism, epidemiology, pathogenesis, clinical manifestations, therapeutic strategies, and preventive measures concerning human mucormycosis, while summarizing the single center experience of mucormycosis during one-year period at a Teaching Hospital situated in Sri Lanka.

Reviews in Medical Microbiology
Rajarata University of Sri Lanka (LK)
Good health and well-being
Openalex Percentile: Top 8%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.